Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Shaobo Ding, [email protected] These authors have contributed equally to this work This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
This Privacy Policy does not apply to any Personal Information that you provide to these other websites and services
After starting subcutaneous semaglutide, the patient required a 25% reduction in levothyroxine dose to bring TSH back into the normal range
Statistical analysis Statistical analyses were performed using GraphPad Prism 8 (Graphpad Software Inc., La Jolla, CA, USA)
Talk to your healthcare provider to determine whether treatment is appropriate
Furthermore, SCD1 suppression reversed epithelial-to-mesenchymal transition and reduced the GC metastasis probability both in vitro and in vivo
US$ 21.10
US$ 20.07
US$ 27.80
